BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11535577)

  • 1. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.
    Glover DK; Ruiz M; Takehana K; Petruzella FD; Riou LM; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
    Circulation; 2001 Sep; 104(10):1181-7. PubMed ID: 11535577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist.
    Patel RA; Glover DK; Broisat A; Kabul HK; Ruiz M; Goodman NC; Kramer CM; Meerdink DJ; Linden J; Beller GA
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H637-42. PubMed ID: 19502555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
    Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
    Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.
    Glover DK; Ruiz M; Takehana K; Petruzella FD; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3164-71. PubMed ID: 17308004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation.
    Riou LM; Ruiz M; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA; Glover DK
    J Am Coll Cardiol; 2002 Nov; 40(9):1687-94. PubMed ID: 12427424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism.
    Reece TB; Kron IL; Okonkwo DO; Laurent JJ; Tache-Leon C; Maxey TS; Ellman PI; Linden J; Tribble CG; Kern JA
    J Vasc Surg; 2006 Aug; 44(2):392-7. PubMed ID: 16890874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist.
    Glover DK; Ruiz M; Yang JY; Koplan BA; Allen TR; Smith WH; Watson DD; Barrett RJ; Beller GA
    Circulation; 1996 Oct; 94(7):1726-32. PubMed ID: 8840867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial blood flow and myocardial uptake of (201)Tl and (99m)Tc-sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A(2A) receptor agonist.
    He ZX; Cwajg E; Hwang W; Hartley CJ; Funk E; Michael LH; Verani MS
    Circulation; 2000 Jul; 102(4):438-44. PubMed ID: 10908217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation.
    Peirce SM; Skalak TC; Rieger JM; Macdonald TL; Linden J
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H67-74. PubMed ID: 11406470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion.
    Cassada DC; Tribble CG; Laubach VE; Nguyen BN; Rieger JM; Linden J; Kaza AK; Long SM; Kron IL; Kern JA
    J Vasc Surg; 2001 Sep; 34(3):482-8. PubMed ID: 11533601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion.
    Fiser SM; Tribble CG; Kaza AK; Long SM; Kern JA; Cassada DC; Linden J; Rieger J; Laubach VE; Matisoff A; Kron IL
    J Thorac Cardiovasc Surg; 2002 Nov; 124(5):973-8. PubMed ID: 12407381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma.
    Reece TB; Davis JD; Okonkwo DO; Maxey TS; Ellman PI; Li X; Linden J; Tribble CG; Kron IL; Kern JA
    J Surg Res; 2004 Sep; 121(1):130-4. PubMed ID: 15313386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
    Glover DK; Riou LM; Ruiz M; Sullivan GW; Linden J; Rieger JM; Macdonald TL; Watson DD; Beller GA
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1851-8. PubMed ID: 15591104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion.
    Cassada DC; Tribble CG; Kaza AK; Fiser SM; Long SM; Linden J; Rieger JM; Kron IL; Kern JA
    Surgery; 2001 Aug; 130(2):230-5. PubMed ID: 11490354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons.
    Cassada DC; Tribble CG; Long SM; Kaza AK; Linden J; Rieger JM; Rosin D; Kron IL; Kern JA
    Ann Thorac Surg; 2002 Sep; 74(3):846-9; discussion 849-50. PubMed ID: 12238849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective adenosine A receptor agonist, ATL-146e, attenuates stress-induced gastric lesions in rats.
    Odashima M; Otaka M; Jin M; Komatsu K; Wada I; Matsuhashi T; Horikawa Y; Hatakeyama N; Oyake J; Ohba R; Linden J; Watanabe S
    J Gastroenterol Hepatol; 2005 Feb; 20(2):275-80. PubMed ID: 15683432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adenosine 2A receptor agonist ATL-146e attenuates experimental posthemorrhagic vasospasm.
    Chang CZ; Dumont AS; Simsek S; Titus BJ; Kwan AL; Kassell NF; Solenski NJ
    Neurosurgery; 2007 Jun; 60(6):1110-7; discussion 1117-8. PubMed ID: 17538386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of increased lipid concentration and hyperemic blood flow on the intrinsic myocardial washout kinetics of (99m)TcN-NOET.
    Riou LM; Unger S; Toufektsian MC; Ruiz M; Watson DD; Beller GA; Glover DK
    J Nucl Med; 2003 Jul; 44(7):1092-8. PubMed ID: 12843227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice.
    Odashima M; Otaka M; Jin M; Horikawa Y; Matsuhashi T; Ohba R; Linden J; Watanabe S
    Biochem Biophys Res Commun; 2006 Sep; 347(4):949-54. PubMed ID: 16859640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.